AGM Presentation and Chairmans Address
Filed with ASX · · 39 pages · English
Genetic Technologies Limited on 6ix
In the deck
Story so far
Earlier from Genetic Technologies
- Genetype for Ovarian Cancer published in European Journal
- GeneType Outperforms Traditional Risk Assessments
- GTG Building Momentum on Commercial Plans
- Annual Report to Shareholders and Appendix 4E
- Q4 FY22 Results Milestones and Growth
Later from Genetic Technologies
- GeneType Published in PLUS ONE for CVD & Type 2 Diabetes
- Colorectal Cancer Model Presented at ASCOGI Cancer Symposium
- Appendix 4C and Quarterly Business Update December 2022
- GTG to form Strategic Alliance with global leader QIAGEN
- World First Comprehensive Risk Test-Breast & Ovarian Cancer
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies